Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment

Journal of Hypertension

Volumn 16, Issue 6, 1998, Pages 761-769

  Alderman, Michael H ^a   Cohen, Hillel ^a   Madhavan, Shantha ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Blood pressure; Cardiovascular disease; Clinical profile; Hypertensive patients; Risk factors

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLOROTHIAZIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PROPRANOLOL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 0031863221     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816060-00007     Document Type: Article

References (43)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
2. Collins R, Peto R, MacMahon S, Herbert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838.
3. Whelton PK, Williamson JD, Louis GT, Davis BR, Cutler JA, The ALLHAT Research Group. Antihypertensive and lipid-lowering treatment to prevent heart attack trial. Clin Exp Hypertens 1996; 18:569-579.
4. Gifford RW Jr. FDR and hypertension: if we'd only known then what we know now. Geriatrics 1996; 51:29-32.
5. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, et al. Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors. N Engl J Med 1996; 334:884-890.
6. Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in 'mild' hypertension: results of the Hypertension Detection and Follow-up Program. N Engl J Med 1982; 307:976-980.
7. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412.
8. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 1991; 338:1281-1285.
9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265:3255-3264.
10. Kannel WH, Sorlie P. Hypertension in Framingham. In: Paul O (editor): Epidemiology and control of hypertension. New York: Stratton International Medical Book Corp.; 1975. pp. 553-555.
11. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chron Dis 1978; 31:201-306.
12. Alderman MH, Schoenbaum EE. Detection and treatment of hypertension at the work site. W Engl J Med 1975; 293:65-68.
13. Alderman MH, Davis TK. Hypertension control at the work site. J Occup Med 1976; 18:793-796.
14. Alderman MH, Ooi WL, Madhavan S, Cohen H. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA 1989; 262:920-924.
15. Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153:154-183.
16. Joint National Committee. The 1980 report of the National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1980; 140:1280-1285.
17. Joint National Committee. The 1988 report of the National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148:1023-1038.
18. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972; 34:187-220.
19. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324:1098-1104.
20. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23:395-401.
21. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease: the Framingham study. Am J Cardiol 1971; 27:335-346.
22. Kannel WB. Role of blood pressure in cardiovascular morbidity and mortality. Prag Cardiovasc Dis 1974; 17:5-24.
23. McDonough JR, Hames CG, Stulb SC, Garrison GE. Coronary heart disease among negroes and whites in Evans County, Georgia. J Chron Dis 1965; 18:463-468.
24. Enriquez-Sarno M, Klodas E, Garratt KN, Bailey KR, Tajik A, Holmes DR. Secular trends in coronary atherosclerosis - analysis in patients with valvular regurgitation. N Engl J Med 1996; 335:316-322.
25. Bulpitt CJ, Palmer AJ, Fletcher AE, Beevers DG, Coles EC, Ledingham JG, et al. Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994; 90:225-233.
26. Palmer AJ, Fletcher AE, Bulpitt CJ, Beevers DG, Coles EC, Ledingham JG, et al. Alcohol intake and cardiovascular mortality in hypertensive patients: report from the Department of Health Hypertensive Care Computing Project (DHCCP). J Hypertens 1995; 13:957-964.
27. Samuelsson O, Pennert K, Andersson O, Berglund G, Hedner T, Persson B, et al. Diabetes mellitus and raised serum triglycerides concentration in treated hypertension - are they of prognostic importance? Observational study. BMJ 1996; 313:660-663.
28. Alderman MH, Madhavan S, Cohen H. Antihypertensive drug therapy - the effect of JNC criteria on prescribing patterns and patient status through the first year. Am J Hypertens 1996; 9:413-418.
29. Sackett DL. Patients and therapies: getting the two together. N Engl J Med 1987; 298:278-279.
30. Foote A, Erfurt JC. Hypertension control at the work site: comparisons of screening and referral alone, referral and follow-up, and on-site treatment. N Engl J Med 1983; 308:809-813.
31. Logan AG, Milne BJ, Achber C, Campbell WP, Haynes RB. Work-site treatment of hypertension by specifically trained nurses: a controlled trial. Lancet 1979; 2:1175-1178.
32. Schoenbaum EE, Alderman MH. Organization for long-term management of hypertension: the recruitment, training, and responsibilities of a health team. Bull NY Acad Med 1976; 52:699-708.
33. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health 1994; 84:1768-1774.
34. Harms LM, Schellvis FG, van Eijk JT, Donker AJ, Bouter LM. Cardiovascular morbidity and mortality among hypertensive patients in general practice: the evaluation of long-term systematic management. J Clin Epidemiol 1997; 50:779-786.
35. Herbert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153:578-581.
36. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996; 148:141-149.
37. The SOLVD Investigators. Effect of enalapril on survival inpatients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293-302.
38. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325:303-310.
39. Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. Arch Intern Med 1990; 150:769-773.
40. MacMahon S. Blood pressure and the risks of cardiovascular disease. In: Swales JD (editor): Textbook of hypertension. Oxford: Blackwell; 1994. pp. 46-57.
41. Mancia G, Grassi G. Considerations on current and future trials in hypertension. Blood Pressure 1996; 5:327-332.
42. Kawachi I, Purdie G. Should treatment of mild to moderate hypertension be targeted? Results from a Markov cohort model incorporating multiple risk factors. J Hum Hypertens 1990; 4:651-658.
43. Elmore JG, Viscoli CM, Horwitz RI. The evolving clinical status of patients after a myocardial infarction: the importance of post-hospital data for mortality prediction. J Clin Epidemiol 1996; 49:1233-1235.